1419 — Human Health Holdings Income Statement
0.000.00%
- HK$318.82m
- HK$13.46m
- HK$644.43m
- 98
- 96
- 19
- 86
Annual income statement for Human Health Holdings, fiscal year end - June 30th, HKD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 655 | 1,122 | 1,002 | 591 | 644 |
| Cost of Revenue | |||||
| Gross Profit | 377 | 660 | 593 | 271 | 297 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 484 | 672 | 753 | 555 | 608 |
| Operating Profit | 171 | 450 | 249 | 36.1 | 36.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 169 | 445 | 239 | 26.6 | 29.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 144 | 375 | 181 | 24.2 | 26.6 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 144 | 375 | 181 | 24.2 | 26.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 144 | 375 | 181 | 24.2 | 26.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.338 | 1 | 0.598 | 0.097 | 0.086 |
| Dividends per Share |